Return to Issue Details
RESULTS OF NEOADJUVANT CHEMOTHERAPY TREATMENT FOR HER2(+) BREAST CANCER USING A COMBINATION CHEMOTHERAPY REGIMEN WITH HER2 INHIBITORS AT NGHE AN ONCOLOGY HOSPITAL.
Download
Download PDF